Table 6.

Adverse events in the treated population

Adverse event	Grades 1 & 2	Grade ≥ 3	Total
Hematologic adverse events
Neutropenia	1 (2.3)	5 (11.4)	6 (13.7)
Thrombocytopenia	2 (4.5)	3 (6.8)	5 (11.4)
Anemia	1 (2.3)	0	1 (2.3)
Gastrointestinal adverse events
Nausea	2 (4.5)	0	2 (4.5)
Vomiting	1 (2.3)	0	1 (2.3)
Constipation	3 (6.8)	0	3 (6.8)
Diarrhea	2 (4.5)	0	2 (4.5)
Hepatobiliary adverse events
Elevated transaminase levels	1 (2.3)	1 (2.3)	2 (4.5)
Other
Neuropathy	9 (20.5)	0	9 (20.5)
Infection	8 (18.2)	1 (2.3)	9 (20.5)
Rash	5 (11.4)	0	5 (11.4)
Insomnia	4 (9.1)	0	4 (9.1)
Fatigue	6 (13.7)	0	6 (13.7)
Dizziness	1 (2.3)	0	1 (2.3)

Values are presented as number (%).